Evaluation of pharmacist intervention for inhalation therapy in patients with chronic obstructive pulmonary disease (COPD) and asthma.

Evaluation of pharmacist intervention for inhalation therapy in patients with chronic obstructive pulmonary disease (COPD) and asthma. - Evaluation of pharmacist intervention for inhalation therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027281

Enrollment

Registered

2017-05-10

Start date

2017-04-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease (COPD), asthma

Interventions

questionnaire about inhalation therapy, assessment and education of inhalation technique (every visit to a trial phamacy, 4-8 times for four months)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: COPD or asthma outpatients treated with inhalation therapy for more than three months

Exclusion criteria

Exclusion criteria: Patients are excluded if they have cancer, sever liver or renal dysfunction, and difficulty of inhaling by themselves.

Design outcomes

Primary

Measure	Time frame
inhalation technique	—

Secondary

Measure	Time frame
SpO2, peak flow rate, subjective symptoms, adherence	—

Countries

Japan

Contacts

Public ContactEisaku Tomioka

Nakanobu Dispensing Pharmacy Pharmacy

nakanobu-p@ip-members.net03-5749-3507

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026